Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 318

1.

Time is running out for sand.

Bendixen M, Best J, Hackney C, Iversen LL.

Nature. 2019 Jul;571(7763):29-31. doi: 10.1038/d41586-019-02042-4. No abstract available.

PMID:
31267054
2.

Sexual conflict and intrasexual polymorphism promote assortative mating and halt population differentiation.

Iversen LL, Svensson EI, Christensen ST, Bergsten J, Sand-Jensen K.

Proc Biol Sci. 2019 Mar 27;286(1899):20190251. doi: 10.1098/rspb.2019.0251.

PMID:
30890096
3.

Funding agencies can prevent harassment.

Iversen LL, Bendixen M.

Science. 2018 Jul 13;361(6398):140. doi: 10.1126/science.aau3979. No abstract available.

PMID:
30002247
4.

Greenland: Build an economy on sand.

Bendixen M, Iversen LL, Overeem I.

Science. 2017 Nov 17;358(6365):879. doi: 10.1126/science.aar3388. No abstract available.

PMID:
29146801
5.

Time-restricted flight ability influences dispersal and colonization rates in a group of freshwater beetles.

Iversen LL, Rannap R, Briggs L, Sand-Jensen K.

Ecol Evol. 2017 Jan 4;7(3):824-830. doi: 10.1002/ece3.2680. eCollection 2017 Feb.

6.

A Learned Society's Perspective on Publishing.

Suzuki K, Edelson A, Iversen LL, Hausmann L, Schulz JB, Turner AJ.

J Neurochem. 2016 Oct;139 Suppl 2:17-23. doi: 10.1111/jnc.13674. Epub 2016 Aug 17. Review.

7.

Rita Levi-Montalcini: Neuroscientist par excellence.

Iversen LL.

Proc Natl Acad Sci U S A. 2013 Mar 26;110(13):4862-3. doi: 10.1073/pnas.1301976110. Epub 2013 Mar 20. No abstract available.

8.

Detection of a diverse marine fish fauna using environmental DNA from seawater samples.

Thomsen PF, Kielgast J, Iversen LL, Møller PR, Rasmussen M, Willerslev E.

PLoS One. 2012;7(8):e41732. doi: 10.1371/journal.pone.0041732. Epub 2012 Aug 29.

9.

Monitoring endangered freshwater biodiversity using environmental DNA.

Thomsen PF, Kielgast J, Iversen LL, Wiuf C, Rasmussen M, Gilbert MT, Orlando L, Willerslev E.

Mol Ecol. 2012 Jun;21(11):2565-73. doi: 10.1111/j.1365-294X.2011.05418.x. Epub 2011 Dec 13.

PMID:
22151771
10.

Lack of consensus between general practitioners and official guidelines on alcohol abstinence during pregnancy.

Kesmodel US, Kesmodel PS, Iversen LL.

Dan Med Bull. 2011 Oct;58(10):A4327.

PMID:
21975156
11.

Dopamine: 50 years in perspective.

Iversen SD, Iversen LL.

Trends Neurosci. 2007 May;30(5):188-93. Epub 2007 Mar 26. Review.

PMID:
17368565
12.

Hemostatic alterations in patients with benign and malignant colorectal disease during major abdominal surgery.

Modrau II, Iversen LL, Thorlacius-Ussing OO.

Thromb Res. 2001 Dec 1;104(5):309-15.

PMID:
11738072
13.

The discovery of monoamine transporters and their role in CNS drug discovery.

Iversen LL.

Brain Res Bull. 1999 Nov-Dec;50(5-6):379. No abstract available.

PMID:
10643444
14.

The uptake of catechol amines at high perfusion concentrations in the rat isolated heart: a novel catechol amine uptake process. 1964.

Iversen LL.

Br J Pharmacol. 1997 Feb;120(4 Suppl):267-82; discussion 264-6. No abstract available.

15.

How does morphine work?

Iversen LL.

Nature. 1996 Oct 31;383(6603):759-60. No abstract available.

PMID:
8892994
16.

Smoking...harmful to the brain.

Iversen LL.

Nature. 1996 Jul 18;382(6588):206-7. No abstract available.

PMID:
8717033
17.

The toxicity in vitro of beta-amyloid protein.

Iversen LL, Mortishire-Smith RJ, Pollack SJ, Shearman MS.

Biochem J. 1995 Oct 1;311 ( Pt 1):1-16. Review. No abstract available.

18.

Neuropeptides: promise unfulfilled?

Iversen LL.

Trends Neurosci. 1995 Feb;18(2):49-50. Review. No abstract available.

PMID:
7537403
19.

The glycine site on the NMDA receptor: structure-activity relationships and therapeutic potential.

Leeson PD, Iversen LL.

J Med Chem. 1994 Nov 25;37(24):4053-67. Review. No abstract available.

PMID:
7990104
20.

Biological properties of the benzodiazepine amidine derivative L-740,093, a cholecystokinin-B/gastrin receptor antagonist with high affinity in vitro and high potency in vivo.

Patel S, Smith AJ, Chapman KL, Fletcher AE, Kemp JA, Marshall GR, Hargreaves RJ, Ryecroft W, Iversen LL, Iversen SD, et al.

Mol Pharmacol. 1994 Nov;46(5):943-8.

PMID:
7969084
21.

Mechanism of inositol monophosphatase, the putative target of lithium therapy.

Pollack SJ, Atack JR, Knowles MR, McAllister G, Ragan CI, Baker R, Fletcher SR, Iversen LL, Broughton HB.

Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):5766-70.

22.
23.

Neuroprotective NMDA antagonists: the controversy over their potential for adverse effects on cortical neuronal morphology.

Hargreaves RJ, Hill RG, Iversen LL.

Acta Neurochir Suppl (Wien). 1994;60:15-9. Review.

PMID:
7976530
24.
25.

Dopamine receptors. The D4 and schizophrenia.

Iversen LL.

Nature. 1993 Sep 30;365(6445):393. No abstract available.

PMID:
8413582
26.

Pharmacology. Medical uses of marijuana?

Iversen LL.

Nature. 1993 Sep 2;365(6441):12-3. No abstract available.

PMID:
8395659
27.
28.

Approaches to rational drug development in Alzheimer's disease.

Iversen LL, Iversen SD, Freedman SB, Dawson G, Rupniak N, Hargreaves RJ, Showell GA, Street LJ, Baker R.

Drug Des Discov. 1993;9(3-4):251-9. Review. No abstract available.

PMID:
8400006
29.

Approaches to cholinergic therapy in Alzheimer's disease.

Iversen LL.

Prog Brain Res. 1993;98:423-6. Review. No abstract available.

PMID:
8248531
30.

Cost of brain disorders.

Bloom FE, Cowey A, Faull RL, Grahame-Smith DG, Gray JA, Hökfelt T, Iversen LL, Llinas RR, Marsden CD, Purpura DP, et al.

Nature. 1992 Jul 16;358(6383):184. No abstract available.

PMID:
1630482
31.

Molecular cloning of a serotonin receptor from human brain (5HT1E): a fifth 5HT1-like subtype.

McAllister G, Charlesworth A, Snodin C, Beer MS, Noble AJ, Middlemiss DN, Iversen LL, Whiting P.

Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5517-21.

32.

L-687,306: a functionally selective and potent muscarinic M1 receptor agonist.

Freedman SB, Patel S, Harley EA, Iversen LL, Baker R, Showell GA, Saunders J, McKnight A, Newberry N, Scholey K, et al.

Eur J Pharmacol. 1992 Apr 29;215(1):135-6.

PMID:
1516645
33.

Cholecystokinin receptors: synthetic antagonists with selectivity for receptor subtypes and possible clinical applications.

Iversen LL, Dourish CT, Iversen SD.

Biochem Soc Trans. 1991 Nov;19(4):913-5. Review. No abstract available.

PMID:
1794582
34.

Pharmacological specificity of novel, synthetic, cyclic peptides as antagonists at tachykinin receptors.

McKnight AT, Maguire JJ, Elliott NJ, Fletcher AE, Foster AC, Tridgett R, Williams BJ, Longmore J, Iversen LL.

Br J Pharmacol. 1991 Oct;104(2):355-60.

35.

Autoradiographic assessment of the effects of N-methyl-D-aspartate (NMDA) receptor antagonists in vivo.

McCulloch J, Iversen LL.

Neurochem Res. 1991 Sep;16(9):951-63. Review. No abstract available.

PMID:
1686067
36.

Pharmacological approaches to the treatment of ischaemic neuronal damage.

Iversen LL.

Eye (Lond). 1991;5 ( Pt 2):193-7. Review.

PMID:
1830010
38.

Novel quinuclidine-based ligands for the muscarinic cholinergic receptor.

Saunders J, Cassidy M, Freedman SB, Harley EA, Iversen LL, Kneen C, MacLeod AM, Merchant KJ, Snow RJ, Baker R.

J Med Chem. 1990 Apr;33(4):1128-38.

PMID:
2319559
39.

Phencyclidine, dizocilpine, and cerebrocortical neurons.

Allen HL, Iversen LL.

Science. 1990 Jan 12;247(4939):221. No abstract available.

PMID:
2403696
40.
41.

Therapeutic potential of NMDA receptor antagonists as neuroprotective agents.

Foster AC, Gill R, Iversen LL, Kemp JA, Wong EH, Woodruff GN.

Prog Clin Biol Res. 1990;361:301-29. Review. No abstract available.

PMID:
2149761
42.

Central actions of substance P and related tachykinins.

Iversen LL.

J Psychopharmacol. 1989 Jan;3(1):1-6. doi: 10.1177/026988118900300101. No abstract available.

PMID:
22156304
43.

7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex.

Kemp JA, Foster AC, Leeson PD, Priestley T, Tridgett R, Iversen LL, Woodruff GN.

Proc Natl Acad Sci U S A. 1988 Sep;85(17):6547-50.

44.

Differences between high-affinity forskolin binding sites in dopamine-rich and other regions of rat brain.

Poat JA, Cripps HE, Iversen LL.

Proc Natl Acad Sci U S A. 1988 May;85(9):3216-20. Erratum in: Proc Natl Acad Sci U S A 1988 Aug;85(15):5743.

45.

In vitro selectivity of agonists and antagonists for beta 1- and beta 2-adrenoceptor subtypes in rat brain.

Beer M, Richardson A, Poat J, Iversen LL, Stahl SM.

Biochem Pharmacol. 1988 Mar 15;37(6):1145-51.

PMID:
2895652
47.

Biochemical measurement of muscarinic receptor efficacy and its role in receptor regulation.

Freedman SB, Harley EA, Iversen LL.

Trends Pharmacol Sci. 1988 Feb;Suppl:54-60. Review. No abstract available.

PMID:
3074538
48.

Neuronal mechanisms: synaptic function.

Iversen LL.

Science. 1988 Jan 8;239(4836):200-1. No abstract available.

PMID:
17732981
49.

Neuropeptides and their peptidases: Functional considerations.

Littlewood GM, Iversen LL, Turner AJ.

Neurochem Int. 1988;12(3):383-9.

PMID:
20501242
50.

Test models and new directions in dementia research.

Iversen LL.

Psychopharmacol Ser. 1988;5:196-203. Review.

PMID:
3045801

Supplemental Content

Loading ...
Support Center